<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00713908</url>
  </required_header>
  <id_info>
    <org_study_id>20430</org_study_id>
    <nct_id>NCT00713908</nct_id>
  </id_info>
  <brief_title>Voiding Dysfunction in the Postoperative Period Following Placement of the TVT</brief_title>
  <official_title>Voiding Dysfunction in the Postoperative Period Following Placement of the TVT</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Rochester</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Rochester</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate how often women have problems passing their urine&#xD;
      (voiding) after TVT (Tension Free Vaginal Tape) surgery. This will help us to better&#xD;
      understand normal voiding function after surgery as well as to find factors that may help us&#xD;
      predict who will have problems after surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    The Co-Principal Investigator has moved and is no longer interested in continuing this study at&#xD;
    this site.&#xD;
  </why_stopped>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">August 2009</completion_date>
  <primary_completion_date type="Actual">August 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Post-void residual volume</measure>
    <time_frame>Pre-operative and post-operative periods</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>2-day voiding diary, uroflow, standardized questionnaires</measure>
    <time_frame>Pre-operatively and post-operatively</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">2</enrollment>
  <condition>Voiding Dysfunction</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Urogynecology clinic&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of stress incontinence, diagnosis must be confirmed by cough stress test or&#xD;
             multichannel urodynamics&#xD;
&#xD;
          -  Undergoing minimally invasive sling procedure - TVT (by transvaginal or surpapubic&#xD;
             approach)&#xD;
&#xD;
          -  Must be competent to give informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  No diagnosis of stress urinary incontinence&#xD;
&#xD;
          -  Undergoing minimally invasive sling procedure by route other than TVT&#xD;
&#xD;
          -  Undergoing any other pelvic organ prolapse repair procedures&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Known voiding dysfunction preoperatively&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael K. Flynn, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Rochester</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Rochester</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2009</verification_date>
  <study_first_submitted>July 8, 2008</study_first_submitted>
  <study_first_submitted_qc>July 11, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 14, 2008</study_first_posted>
  <last_update_submitted>December 15, 2009</last_update_submitted>
  <last_update_submitted_qc>December 15, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 16, 2009</last_update_posted>
  <responsible_party>
    <name_title>Michael K. Flynn, MD</name_title>
    <organization>University of Rochester</organization>
  </responsible_party>
  <keyword>Voiding dysfunction following TVT placement</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

